Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole

Int J Neuropsychopharmacol. 2007 Feb;10(1):149-51. doi: 10.1017/S1461145706007115. Epub 2006 Aug 31.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amisulpride
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Aripiprazole
  • Dopamine Agonists / therapeutic use*
  • Dopamine Antagonists / adverse effects*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hyperprolactinemia / chemically induced*
  • Hyperprolactinemia / drug therapy
  • Middle Aged
  • Piperazines / therapeutic use*
  • Quinolones / therapeutic use*
  • Schizophrenia / drug therapy
  • Sulpiride / adverse effects
  • Sulpiride / analogs & derivatives*
  • Treatment Failure

Substances

  • Antipsychotic Agents
  • Dopamine Agonists
  • Dopamine Antagonists
  • Piperazines
  • Quinolones
  • Sulpiride
  • Amisulpride
  • Aripiprazole